Search results

  1. Murph

    A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID, 2025, Bader et al

    This study uses a mouse model that might actually not be too bad. It has not just lung issues but immune, gut and microglia too. I'm really excited about using animal models for me/cfs because I think we desperately need to ramp up how much data we have to get some leads on etiology. Humans are...
  2. Murph

    Caffeine against persistent fatigue in long-COVID: a randomized clinical trial, 2025, Cardoso

    I quit coffee once and the withdrawal gave me full body cramps and reduced my fitness. Took me a few weeks to get back to my baseline (which was good, I was in a decent remission at the time). Never again! I corresponded with Chris Armstrong about it at one point and he was interested that...
  3. Murph

    Can a simple screening test distinguish between ME/CFS sufferers and patients with ME/CFS-like symptoms?, 2025, Habermann-Horstmeier (German)

    I had a really clear period in my illness where I always had the very distinct 24 hour gap from exercise (which made me feel great) to PEM start, but more recently it's been cloudier and more variable as I've got deeper into the illness and my fitness is worse, I'm less ultra-mild, my supplement...
  4. Murph

    Preprint RS-fMRI Evidence of Left Frontal Lobe Developmental Deviation as a Potential Pathognomonic Feature of Autism Spectrum, 2025, Tien-Wen Lee

    My son has ASD and this describes him to a tee: "compensatory expansion in other brain regions". Age 5, he can barely string a sentence together but reads chapter books and knows a surprising amount about prime numbers.
  5. Murph

    Rapamune / Rapamycin/ mTOR

    100% true this is one of the things people criticised the PACE trial for. I still look forward to their final results but view them with a dollop of extra skepticism. My view is the likely effect is modest, most trial participants will never hear about it. The study looks set to go on to stage...
  6. Murph

    Are there any health advantages to long-term immobility?

    I genuinely like to think about this. Without mecfs I might have been in a serious bike crash, would probably have worn out the meniscus in my knees from running. But the biggest upside is probably that I had to quit drinking. I was probably on track to make a lot of bad choices and destroy my...
  7. Murph

    Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling, 2025, Yang et al.

    This scientific paper is one of the ones that comes with a reference section, happily. 15. C. G. Boer, D. Radjabzadeh, C. Medina-Gomez, S. Garmaeva, D. Schiphof, P. Arp, T. Koet, A. Kurilshikov, J. Fu, M. A. Ikram, S. Bierma-Zeinstra, A. G. Uitterlinden, R. Kraaij, A. Zhernakova, J. B. J. van...
  8. Murph

    Long-term effects of SARS-CoV-2 infection on blood vessels and blood pressure – LOCHINVAR, 2025, Lip et al.

    I think a serpentine monster might have brought it up from the bottom of a very cold lake, and disappeared again before anyone had a chance to take more than a blurry photo. ;) Study is out of Scotland.
  9. Murph

    Opinion mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAIS, 2025, Bar-Tana

    Just want to pop this poster I came across here, @DMissa you might enjoy this. It's blurry but the sumary is that the first 40 people in the big Rapamycin trial were enough to generate statsitical significant positive effects. Just as an anecdote: The times I've been able to maintain an...
  10. Murph

    Rapamune / Rapamycin/ mTOR

    Today on reddit I found a blurry poster that apparnetly reports preliminary findings from the Avik Roy, Maureen Hanson, Gottschalk Rapamycin study. They've put 40 people through their 3-month study of weekly rapamycin dosing and the preliminary results are good. In the charts in the middle you...
  11. Murph

    Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA PAX LC, 2025, Sawano, Iwasaki+

    Just to clarify for anyone else, like me, feeling a bit confused, Nirmatrelvir is the drug name of paxlovid (which is a brand name). Ritonavir is an anti-HIV drug. Why was it was given as part of both sides of the study?
  12. Murph

    Asymmetrical glymphatic dysfunction in patients with long Covid associated neurocognitive impairment- correlation with BBB disruption, 2025, Chaganti+

    Been thinking a lot about cerebral blood flow, which is plainly impaired in POTS. I'm fascinated by the comorbidity of POTS and me/cfs. Could diverse symptoms share a common cause in some cases? I sometimes can't put down occam's razor, even when I am at risk of cutting my finger. Anyway, I...
  13. Murph

    Reversible reduction in brain myelin content upon marathon running, 2025, Ramos-Cabrer et al.

    This is a fascinating hypothesis. Are there other types of tissue that serve as reserve energy? As I understand we use up phosphocreatine, and glycogen, then the body tries to burn fat. But perhaps other things are being burnt too and they're meant to be used only in crisis? Muscle is one...
  14. Murph

    Do you believe that “viral persistence” is the cause of ongoing MECFS and LC?

    At the risk of being pedantic on the any .... Hwang's study on the patient with Li Fraumeni and mecfs showed this. "Measuring the regeneration of phosphocreatine (PCr) after its utilization by exercise in skeletal muscle using 31P-MRS can noninvasively assess mitochondrial ATP synthesis...
  15. Murph

    Preprint An interorgan neuroimmune circuit promotes visceral hypersensitivity, 2025, Kim+

    You have to love when vague, general pain symptoms end up having an identifiable neural basis. Another one taken from our old friends the psychologists by good science.
  16. Murph

    Preprint Demonstrating the potential of untargeted hair proteomics for personalized biomarkers in stress-associated disorders, 2025, Sicorello et al

    love it. I'm all for exploration of samples that are easiest to collect, least invasive, easiest to send by mail. That's how you cut costs and lift sample size. Obviously if it shows nothing it's not worth it but we've recently seen some interesting results in saliva and urine. Not everything...
  17. Murph

    Open Master’s Thesis: seeking perceptions about chronic fatigue syndrome in the workplace from working people who both have and do not have ME/CFS

    I found that survey to be a bit of a pigsty. Didn't ask any questions that might have got information from me, and I have quite an extensive employment history during mecfs. Garbage going in ....
  18. Murph

    News from Australia

    Emerge ran a competition for the best story about Long covid. the winner was Hayley Gleeson, published at the ABC: https://www.abc.net.au/news/2024-06-16/children-with-long-covid-dismissed-doctors-myth-virus-harmless/103959078 your boy murph was a runner-up in the comp.
  19. Murph

    Geographic Disparities and Emerging Hotspot Trends of Long COVID in the United States, 2025, Gourishankar

    I'm keen on this kind of basic epidemiology, I have suspicions that populations are not equally prone to me/cfs even after controlling for pre-existing health outcomes. I have been prone to thinking of me/cfs as a disease mostly of the north sea populations and their diaspora (my forebears...
  20. Murph

    Thesis Sequencing B cell receptor repertoires in human disease: applications in ME/CFS and in experimental malaria infection, 2024, Ryback

    Very nice explanation. You're an asset to this forum, thanks for all your contributions!
Back
Top Bottom